1. Cardiac Involvement In Multiorgan Sarcoidosis: Prognostic and Therapeutic Implications
- Author
-
A.J. Chamorro, Cecilia Higueruela-Mínguez, Ana Martín-García, Silvio Ragozzino, and Miguel Marcos
- Subjects
medicine.medical_specialty ,Cardiology ,Disease ,030204 cardiovascular system & hematology ,cardiac sarcoidosis ,cardiac magnetic resonance ,03 medical and health sciences ,Therapeutic approach ,0302 clinical medicine ,Rheumatology ,medicine ,Internal Medicine ,steroid therapy ,Young adult ,multiorgan sarcoidosis ,Intensive care medicine ,Lymph node ,Clinical scenario ,business.industry ,General Engineering ,medicine.disease ,medicine.anatomical_structure ,Granulomatous disease ,Risk stratification ,Sarcoidosis ,prognosis ,business ,030217 neurology & neurosurgery - Abstract
Sarcoidosis is a systemic granulomatous disease with a highly variable clinical impact. Accurate prognostic evaluation is fundamental to establish the best therapeutic approach. Multiorgan disease and especially the involvement of vital organs, such as the heart, are associated with worse outcomes and often require more aggressive therapy. Here, we describe the case of a young adult with sarcoidosis with lymph node, pulmonary, hepatosplenic, and cardiac involvement. This clinical scenario emphasizes the importance of a thorough prognostic assessment and highlights some of the main unmet clinical needs for the risk stratification and management of these patients.
- Published
- 2020